J. Müller-Brand

发表

Radioiodine therapy in hyperthyroidism: inverse correlation of pretherapeutic iodine uptake level and post‐therapeutic outcome

M. Walter, M. Christ-Crain, B. Eckard, 2004, European journal of clinical investigation.

Gate-keeper to coronary angiography: comparison of exercise testing, myocardial perfusion SPECT and individually tailored approach for risk stratification

M. Pfisterer, J. Müller-Brand, S. Muzzarelli, 2010, The International Journal of Cardiovascular Imaging.

Interrelation of ST-segment depression during bicycle ergometry and extent of myocardial ischaemia by myocardial perfusion SPECT

M. Pfisterer, J. Müller-Brand, S. Muzzarelli, 2009, European Journal of Nuclear Medicine and Molecular Imaging.

Cohort study of somatostatin-based radiopeptide therapy with [(90)Y-DOTA]-TOC versus [(90)Y-DOTA]-TOC plus [(177)Lu-DOTA]-TOC in neuroendocrine cancers.

C. Rochlitz, M. Briel, M. Walter, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Enhancement of radioiodine uptake in hyperthyroidism by administration of hydrochlorothiazide

M. Walter, E. Nitzsche, J. Müller-Brand, 2003, European Journal of Nuclear Medicine and Molecular Imaging.

Response to [90Yttrium-DOTA]-TOC Treatment is Associated with Long-term Survival Benefit in Metastasized Medullary Thyroid Cancer: A Phase II Clinical Trial

C. Rochlitz, M. Walter, C. Schindler, 2007, Clinical Cancer Research.

Prospective evaluation of an algorithm for the functional assessment of lung resection candidates.

C. Bolliger, C. Bolliger, J. Müller-Brand, 1999, American journal of respiratory and critical care medicine.

Combined acebutolol/nifedipine therapy in patients with chronic coronary artery disease: additional improvement of ischemia-induced left ventricular dysfunction.

M. Pfisterer, J. Müller-Brand, F. Burkart, 1982, The American journal of cardiology.

Noninvasive stress testing of myocardial ischemia: comparison of GRE-MRI perfusion and wall motion analysis to 99 mTc-MIBI-SPECT, relation to coronary angiography

M. Pfisterer, W. Steinbrich, G. Bongartz, 1997, European Radiology.

Macrocyclic chelator-coupled gastrin-based radiopharmaceuticals for targeting of gastrin receptor-expressing tumours

M. Walter, J. Müller-Brand, J. Reubi, 2008, European Journal of Nuclear Medicine and Molecular Imaging.

Thallium-201 myocardial scintigraphy in coronary triple-vessel disease: An attempt to increase sensitivity using quantitative methods

M. Pfisterer, J. Müller-Brand, R. Fridrich, 2004, European Journal of Nuclear Medicine.

Human ketone body production and utilization studied using tracer techniques: regulation by free fatty acids, insulin, catecholamines, and thyroid hormones.

J. Müller-Brand, U. Keller, W. Stauffacher, 1989, Diabetes/metabolism reviews.

Evaluation of high-risk lung resection candidates: pulmonary haemodynamics versus exercise testing. A series of five patients.

C. Bolliger, J. Müller-Brand, P. Stulz, 1994, Respiration; international review of thoracic diseases.

Clinical value of a mucin-like carcinoma-associated antigen in monitoring breast cancer patients in comparison with CA 15-3.

J. Müller-Brand, A. Miserez, R. Fridrich, 1991, European journal of cancer.

Impact of concomitant thyroid pathology on preoperative workup for primary hyperparathyroidism

J. Müller-Brand, D. Oertli, C. Viehl, 2009, European journal of medical research.

Assessment of the extent of jeopardized myocardium during acute coronary artery occlusion followed by reperfusion in man using technetium-99m isonitrile imaging.

M. Pfisterer, J. Müller-Brand, W. Kiowski, 1991, American heart journal.

Predictors and prognostic impact of silent coronary artery disease in asymptomatic high-risk patients with diabetes mellitus.

M. Pfisterer, J. Müller-Brand, R. Jeger, 2017, International journal of cardiology.

Progression to overt or silent CAD in asymptomatic patients with diabetes mellitus at high coronary risk: main findings of the prospective multicenter BARDOT trial with a pilot randomized treatment substudy.

M. Pfisterer, S. von Felten, J. Müller-Brand, 2014, JACC. Cardiovascular imaging.

Silent ischemia after percutaneous transluminal coronary angioplasty: incidence and prognostic significance.

M. Pfisterer, J. Müller-Brand, P. Rickenbacher, 1993, Journal of the American College of Cardiology.

Relationship between the resting heart rate and the extent of coronary artery disease as assessed by myocardial perfusion SPECT.

J. Müller-Brand, S. Muzzarelli, A. Kõhler, 2012, Swiss medical weekly.

[Validation study of the sentinel lymph node (SLN) method in invasive breast carcinoma. Personal data and review of the literature].

J. Torhorst, J. Müller-Brand, I. Langer, 2000, Swiss surgery = Schweizer Chirurgie = Chirurgie suisse = Chirurgia svizzera.

Central nervous system lupus: Concomitant occurrence of myelopathy and cognitive dysfunction

J. Müller-Brand, E. Radü, A. Plohmann, 1994, Clinical Rheumatology.

Somatostatin Receptor–Targeted Radiopeptide Therapy with 90Y-DOTATOC and 177Lu-DOTATOC in Progressive Meningioma: Long-Term Results of a Phase II Clinical Trial

M. Briel, M. Walter, J. Müller-Brand, 2015, The Journal of Nuclear Medicine.

in neuroendocrine tumours

C. Rochlitz, M. Briel, M. Walter, 2014 .

Somatostatin-based radiopeptide therapy with [177Lu-DOTA]-TOC versus [90Y-DOTA]-TOC in neuroendocrine tumours

C. Rochlitz, M. Briel, M. Walter, 2014, European Journal of Nuclear Medicine and Molecular Imaging.

Somatostatin-based radiotherapy with [90Y-DOTA]-TOC in neuroendocrine tumors: long-term outcome of a phase I dose escalation study

C. Rochlitz, M. Briel, M. Walter, 2013, Journal of Translational Medicine.

The Dental Safety Profile of High-Dose Radioiodine Therapy for Thyroid Cancer: Long-Term Results of a Longitudinal Cohort Study

M. Walter, C. Schindler, J. Müller-Brand, 2007, Journal of Nuclear Medicine.